semaglutide hold for surgery on Semaglutide: Perioperative Safety Guide New Study Recommends Stopping GLP-1
Description
History of constipation If you have a medical history of irritable bowel syndrome with constipation (IBS-C), hypothyroidism, or other motility disorders, the medications may exacerbate symptoms
April 29, 2009
Novo Nordisk stumbles again: CagriSema trails Lillys Zepbound in key trial Novo said its next-gen obesity drug CagriSema hit 23% weight loss at 84 weeks , but it failed to prove non-inferiority versus Lillys tirzepatide (Zepbound) at 25.5%
However, success with these powerful medications requires more than just taking your weekly injectionit demands a comprehensive approach to hydration that acknowledges and addresses the unique challenges these drugs present.The scientific evidence is clear: GLP-1 medications significantly impact your body's hydration balance through multiple mechanisms
[DOI] [PubMed] [Google Scholar] 118
[DOI] [PubMed] [Google Scholar] 111.Lam DH, Watkins ER, Hayward P, Bright J, Wright K, Kerr N, et al
